Aidoc vs Avicenna.AI
Updated October 16, 2026
Radiology departments adding AI to catch urgent findings sooner often compare Aidoc and Avicenna.AI. Aidoc runs a broad platform that flags acute findings and routes alerts to radiologists and care teams across a health system, while Avicenna.AI focuses on cleared CT tools for stroke, embolism, and spine findings delivered inside existing PACS. Scale and breadth separate them more than accuracy claims.
Our analysts compared Aidoc and Avicenna.AI on cleared indications, workflow routing, deployment, care team alerts, and vendor maturity, using the HIR review of each company and Aidoc's news page. In the following sections, we compare them in one table, describe the department each serves, and list Aidoc's news this year.
Aidoc vs Avicenna.AI at a glance, October 2026
| What buyers weigh | Aidoc | Avicenna.AI |
|---|---|---|
| Pricing model | Often a platform fee plus a charge per study or per package of algorithms. | Software licenses for the CT AI modules and the layer that routes results, priced by site and volume. |
| What drives cost | Connecting to PACS and training radiologists, on top of the license. | Which cleared modules you need, the number of sites, scan volume, and how results are routed. |
| Main job | Always-on triage and notification for suspected acute findings across imaging studies. | CT triage and incidental-finding AI delivered into the radiologist PACS and RIS. |
| Breadth | A platform with many FDA-cleared algorithms; buyers who want one narrow algorithm are a weak fit. Clear edge | Focused on CT: neurovascular, pulmonary embolism, spine, and related emergency findings. |
| Alert results | Scores 8.3 on getting alerts to radiologists faster. Higher score | Scores 7.2 on useful CT triage alerts. |
| Product depth | Scores 8.0 on FDA-cleared findings covered. Higher score | Scores 7.1 on CINA and CT AI product depth. |
| Fitting into PACS | Scores 7.5; first acute algorithms in the worklist 10-18 weeks after kickoff. Higher score | Scores 6.6; integration takes 4-12 weeks, then a 4-8 week pilot at one site. |
| Alert noise | Too many low-value alerts make radiologists stop trusting the queue; plan alert governance. | Needs staff for alert review and false-positive handling. |
| Time to full value | About 6 to 13 months | Not published |
| What you need first | IT time to connect to PACS and the EHR, and a radiology IT owner. | A clinical owner in radiology or cardiology, plus imaging IT. |
| Deal-breaker | No one in radiology IT will manage where AI alerts go. | No imaging IT or clinical owner. |
| Pricing clarity score | 7.2 Clearer pricing | 6.5 |
| HIR overall score | 7.9, Recommend. Higher score | 6.9, Conditional. |
| Best for | Health systems operationalizing always-on triage for acute findings. | Hospitals and teleradiology groups that need FDA-cleared CT triage AI for neurovascular, PE, spine, and related emergency findings. |
| Not a fit for | Sites without radiology IT ownership for AI alert routing. | Sites without CT emergency volume to justify triage AI. |
Which fits which buyer
Consider how many findings and sites you want covered.
Choose Aidoc if
- You run a multi-hospital system that wants one AI platform.
- Alerts should reach stroke, PE, and trauma teams as well as radiology.
- You have IT staff to own AI routing.
Choose Avicenna.AI if
- You need CT triage for a focused set of emergency findings.
- You are a teleradiology group or a single hospital.
- You want results to appear in your current PACS without a new viewer.
Verdict
Aidoc scores well ahead and is the stronger platform for health systems. Avicenna.AI is a conditional pick for sites that want targeted CT triage.
Check each indication against your own case mix before buying.
Where the two tools are headed in 2027 and beyond
Aidoc: Aidoc formed a diagnostic AI consortium with twelve health systems on August 11, 2026, won Medicare new technology payment eligibility for its body CT triage on August 13, 2026, and shared Mercy results on August 25, 2026.
Ask both for false-alert rates at a site like yours.
Methodology
Each row comes from the HIR reviews of Aidoc and Avicenna.AI, scored under the HIR method, and from each vendor's public pricing where it exists. Any published price for Aidoc or Avicenna.AI was checked on that vendor's own site on October 16, 2026.
A green check marks a clear edge for Aidoc or Avicenna.AI only where their review scores differ by at least 0.3 points or the two reviews show a plain difference. Rows with nothing published for either Aidoc or Avicenna.AI are left out, and time to full value for each adds up the rollout stages in its review.
Sources
- HIR review of Aidoc and HIR review of Avicenna.AI
- Aidoc website
- Avicenna.AI website
- Aidoc diagnostic AI consortium, August 11, 2026
- Aidoc Medicare payment eligibility, August 13, 2026
- Mercy and Aidoc results, August 25, 2026